(Q43997965)

28 November 2017

Safety and efficacy of daptomycin in the treatment of osteomyelitis: results from the CORE Registry (English)

1 reference

28 November 2017

1 reference

Crompton JA

1

1 reference

28 November 2017

North DS

series ordinal

2

1 reference

28 November 2017

McConnell SA

series ordinal

3

1 reference

28 November 2017

Lamp KC

series ordinal

4

1 reference

28 November 2017

1 August 2009

1 reference

28 November 2017

Journal of Chemotherapy

1 reference

28 November 2017

21

1 reference

28 November 2017

4

1 reference

28 November 2017

414-420

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

28 November 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Systematic review and meta-analysis of antibiotic therapy for bone and joint infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Antimicrobial agents in orthopaedic surgery: Prophylaxis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

In vitro activity of daptomycin against gram-positive European clinical isolates with defined resistance determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

Outcomes of osteomyelitis among patients treated with outpatient parenteral antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2009.21.4.414

10.1179/JOC.2009.21.4.414

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference